Cargando…
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360272/ https://www.ncbi.nlm.nih.gov/pubmed/34383735 http://dx.doi.org/10.15585/mmwr.mm7032e4 |
| _version_ | 1783737711791702016 |
|---|---|
| author | Rosenblum, Hannah G. Hadler, Stephen C. Moulia, Danielle Shimabukuro, Tom T. Su, John R. Tepper, Naomi K. Ess, Kevin C. Woo, Emily Jane Mba-Jonas, Adamma Alimchandani, Meghna Nair, Narayan Klein, Nicola P. Hanson, Kayla E. Markowitz, Lauri E. Wharton, Melinda McNally, Veronica V. Romero, José R. Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Mbaeyi, Sarah A. Oliver, Sara E. |
| author_facet | Rosenblum, Hannah G. Hadler, Stephen C. Moulia, Danielle Shimabukuro, Tom T. Su, John R. Tepper, Naomi K. Ess, Kevin C. Woo, Emily Jane Mba-Jonas, Adamma Alimchandani, Meghna Nair, Narayan Klein, Nicola P. Hanson, Kayla E. Markowitz, Lauri E. Wharton, Melinda McNally, Veronica V. Romero, José R. Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Mbaeyi, Sarah A. Oliver, Sara E. |
| author_sort | Rosenblum, Hannah G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8360272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83602722021-08-17 Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 Rosenblum, Hannah G. Hadler, Stephen C. Moulia, Danielle Shimabukuro, Tom T. Su, John R. Tepper, Naomi K. Ess, Kevin C. Woo, Emily Jane Mba-Jonas, Adamma Alimchandani, Meghna Nair, Narayan Klein, Nicola P. Hanson, Kayla E. Markowitz, Lauri E. Wharton, Melinda McNally, Veronica V. Romero, José R. Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Mbaeyi, Sarah A. Oliver, Sara E. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-08-13 /pmc/articles/PMC8360272/ /pubmed/34383735 http://dx.doi.org/10.15585/mmwr.mm7032e4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Rosenblum, Hannah G. Hadler, Stephen C. Moulia, Danielle Shimabukuro, Tom T. Su, John R. Tepper, Naomi K. Ess, Kevin C. Woo, Emily Jane Mba-Jonas, Adamma Alimchandani, Meghna Nair, Narayan Klein, Nicola P. Hanson, Kayla E. Markowitz, Lauri E. Wharton, Melinda McNally, Veronica V. Romero, José R. Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Mbaeyi, Sarah A. Oliver, Sara E. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title | Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title_full | Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title_fullStr | Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title_full_unstemmed | Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title_short | Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 |
| title_sort | use of covid-19 vaccines after reports of adverse events among adult recipients of janssen (johnson & johnson) and mrna covid-19 vaccines (pfizer-biontech and moderna): update from the advisory committee on immunization practices — united states, july 2021 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360272/ https://www.ncbi.nlm.nih.gov/pubmed/34383735 http://dx.doi.org/10.15585/mmwr.mm7032e4 |
| work_keys_str_mv | AT rosenblumhannahg useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT hadlerstephenc useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT mouliadanielle useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT shimabukurotomt useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT sujohnr useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT teppernaomik useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT esskevinc useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT wooemilyjane useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT mbajonasadamma useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT alimchandanimeghna useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT nairnarayan useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT kleinnicolap useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT hansonkaylae useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT markowitzlaurie useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT whartonmelinda useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT mcnallyveronicav useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT romerojoser useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT talbothkeipp useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT leegracem useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT daleymatthewf useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT mbaeyisaraha useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 AT oliversarae useofcovid19vaccinesafterreportsofadverseeventsamongadultrecipientsofjanssenjohnsonjohnsonandmrnacovid19vaccinespfizerbiontechandmodernaupdatefromtheadvisorycommitteeonimmunizationpracticesunitedstatesjuly2021 |